Related Experiment Video

Updated: Nov 19, 2025

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.3K

The inhibition of HeLa cells proliferation through SPARCL1 mediated by SPP1

Shengpeng Zhang1, Fengge Zhang2, Limin Feng1

  • 1Department of Obstetrics and Gynecology, Beijing Tiantan Hospital, Capital Medical University, No. 119 South Fourth Ring West Road, Fengtai District, Beijing, 100070 P.R. China.

Cytotechnology
|January 28, 2021
PubMed

Insights

Secreted protein acidic and rich in cysteines-like 1 (SPARCL1) suppresses cervical cancer progression by inhibiting cell proliferation, migration, and invasion. Its effects are mediated through Secreted phosphor protein 1 (SPP1) and the FAK/ERK pathway.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Secreted protein acidic and rich in cysteines-like 1 (SPARCL1) is a known tumor suppressor involved in cancer progression.
  • Understanding SPARCL1's role in cervical cancer is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the regulatory role of SPARCL1 in cervical tumor biology.
  • To elucidate the relationship between SPARCL1 and Secreted phosphor protein 1 (SPP1) in cervical cancer cells.

Main Methods:

  • Western blot and RT-PCR to assess SPARCL1 expression.
  • Cell proliferation, migration, and invasion assays (CCK8, colony formation, wound healing, Transwell).
  • Overexpression studies of SPARCL1 and SPP1, and analysis of FAK/ERK pathway phosphorylation.

Main Results:

  • SPARCL1 expression was lower in HeLa cells compared to Ect1/E6E7 cells.
  • SPARCL1 overexpression repressed proliferation, migration, and invasion in HeLa cells.
  • SPARCL1 overexpression downregulated SPP1, and SPP1 overexpression counteracted SPARCL1's effects, inhibiting FAK/ERK phosphorylation.

Conclusions:

  • SPARCL1 acts as a tumor suppressor in cervical cancer by inhibiting cell proliferation, migration, and invasion.
  • SPP1 antagonizes SPARCL1's tumor-suppressive effects, potentially via the FAK/ERK pathway.
  • SPARCL1 and SPP1 represent potential therapeutic targets for cervical cancer treatment.
Keywords:
Cervical cancerFAK/ERKSPARCL1SPP1

More Related Videos

Analysis of Side Population in Solid Tumor Cell Lines06:26

Analysis of Side Population in Solid Tumor Cell Lines

Published on: February 23, 2021

4.6K
Evaluating the Effect of SASP Factors on the Proliferation of Cancer Cells Using a Comparative Analysis of Three Distinct Methodologies08:57

Evaluating the Effect of SASP Factors on the Proliferation of Cancer Cells Using a Comparative Analysis of Three Distinct Methodologies

Published on: September 19, 2025

229

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.3K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
37.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
The Spindle Assembly Checkpoint02:19

The Spindle Assembly Checkpoint

The spindle assembly checkpoint is a molecular surveillance mechanism ensuring the fidelity of chromosome segregation during anaphase. The checkpoint monitors the completion of all the prerequisite steps before chromosome segregation to determine whether the segregation process should proceed or be delayed.
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
3.5K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.7K